NCT03035331
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +31 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
181 public trials
52 recruiting studies
Lymphoma, T-Cell trial results
NCT03902184
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
- Irvine Medical Center Orange, California, United States
- Stanford University Stanford, California, United States
NCT02783625
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of Washington School of Medicine in St. Louis St Louis, Missouri, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT06492304
- Conditions
- Acute Myeloid Leukemia, B Cell Lymphoma, Hematologic Diseases, +15 more
- Locations
-
- Research Site 6 Phoenix, Arizona, United States
- Research Site 5 Stanford, California, United States
- Research Site 3 Boston, Massachusetts, United States
- Research Site 4 New York, United States
NCT05665530
- Conditions
- Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
- Locations
-
- City of Hope Duarte, California, United States
- American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
NCT03210662
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT02588651
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Angioimmunoblastic T-cell Lymphoma, Enteropathy Associated T-cell Lymphoma, +22 more
- Locations
-
- Wayne State University, Karmanos Cancer Institute Detroit, Michigan, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01908777
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
NCT04074746
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States